Iben Daugaard

895 citations
20 papers · 682 · h-index 14

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • RNA Research and Splicing
    • RNA Interference and Gene Delivery

Papers in

    • RNA modifications and cancer 7
    • RNA Research and Splicing 4
    • Circular RNAs in diseases 4
    • Epigenetics and DNA Methylation 3
    • MicroRNA in disease regulation 9
    • Cancer-related molecular mechanisms research 6
    • Cancer Genomics and Diagnostics 2

Iben Daugaard

20 papers receiving 675 citations

Peers

Iben Daugaard
Comparison fields: 5 of 80
  • Cancer Research 403
  • Molecular Biology 567
  • Immunology 54
  • Pathology and Forensic Medicine 45
  • Aging 4
Replace Jayanth Kumar Palanichamy with:
Jayanth Kumar Palanichamy India
Zhengyuan Yu China
Uwe Galli Germany
Eleonora Zonta France
Stefania Oliveto Italy
Salemiz Sandoval United States
Kristina Grabušić Croatia
Li-Juan Ji China
Yian Wang China
Li‐Ting Diao China
Iben Daugaard relative to Jayanth Kumar Palanichamy India Jayanth Kumar Palanichamy's profile →
Citations per field
00.5×1.5×2.0×
Jayanth Kumar Palanichamy · 1×
Citations per year

Countries citing papers authored by Iben Daugaard

Since Specialization
Citations

This map shows the geographic impact of Iben Daugaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iben Daugaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iben Daugaard more than expected).

Fields of papers citing papers by Iben Daugaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iben Daugaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iben Daugaard. The network helps show where Iben Daugaard may publish in the future.

Co-authors

The 25 scholars most cited alongside Iben Daugaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iben Daugaard Line = papers co-authored together Iben Daugaard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2018112
2 2017103
3 201762
4 201461
5 201957
6 201657
7 201735
8 201029
9 201828
10 201926
11 201525
12 201724
13 201724
14 201913
15 20178
16 20207
17 20215
18 20184
19
[Psychiatry--Italy. The best prevention is the closing of psychiatric hospitals].
19861
20 20221

About Iben Daugaard

Iben Daugaard is a scholar working on Molecular Biology, Cancer Research, Genetics, Immunology and Oncology, having authored 20 papers that have together received 682 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), RNA Research and Splicing (4 papers), Circular RNAs in diseases (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (403 citations), Molecular Biology (567 citations), Immunology (54 citations), Pathology and Forensic Medicine (45 citations) and Aging (4 citations). Iben Daugaard has collaborated with scholars based in Denmark, United States and Poland. Frequent co-authors include Thomas B. Hansen, Lise Lotte Hansen, Henrik Hager, Lasse S. Kristensen, Jørgen Kjems, Lotte Victoria Winther Stagsted, Mette Dahl, Kirsten Grønbæk, Irene M. Pedersen and Adam Idica. Their work appears in journals such as Oncotarget, Experimental and Molecular Pathology, Scientific Reports, Oncogenesis and Life Science Alliance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact